WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Alex Kelly, Merck's senior vice president of investor relations, is scheduled to present at the Bank of America Merrill Lynch Global Healthcare Conference in London on Sept. 15 at 3:10 a.m. EDT / 8:10 a.m. GMT. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events-and-presentations/home.html. An archive of the presentation will be available at the same location.
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com.
Steven Campanini, 908-423-4291
Carol Ferguson, 908-423-4465
KEYWORDS: United Kingdom United States Europe North America New Jersey
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Other Health